CALLEGARI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 4.147
AS - Asia 1.880
EU - Europa 1.324
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 44
OC - Oceania 3
Totale 7.748
Nazione #
US - Stati Uniti d'America 4.028
SG - Singapore 698
CN - Cina 464
IT - Italia 342
DE - Germania 237
VN - Vietnam 211
BR - Brasile 183
PL - Polonia 165
HK - Hong Kong 137
GB - Regno Unito 113
UA - Ucraina 100
BD - Bangladesh 98
FI - Finlandia 98
TR - Turchia 64
CA - Canada 61
FR - Francia 51
ID - Indonesia 45
RU - Federazione Russa 38
IN - India 37
MX - Messico 37
JP - Giappone 35
SE - Svezia 35
AR - Argentina 25
NL - Olanda 22
RO - Romania 22
ES - Italia 19
CZ - Repubblica Ceca 16
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 12
PK - Pakistan 12
LT - Lituania 9
UZ - Uzbekistan 9
VE - Venezuela 9
BE - Belgio 8
CO - Colombia 8
GR - Grecia 8
OM - Oman 7
EG - Egitto 6
IE - Irlanda 6
IR - Iran 6
KE - Kenya 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
KR - Corea 5
SA - Arabia Saudita 5
BO - Bolivia 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
HN - Honduras 3
JO - Giordania 3
NP - Nepal 3
SV - El Salvador 3
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
HR - Croazia 2
LV - Lettonia 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 7.642
Città #
Ashburn 515
Fairfield 456
Singapore 431
San Jose 330
Woodbridge 260
Houston 217
Warsaw 164
Seattle 163
Beijing 157
Wilmington 149
Chandler 144
Munich 141
Ann Arbor 139
Santa Clara 136
Cambridge 135
Hong Kong 132
Jacksonville 110
New York 91
Council Bluffs 90
Ferrara 79
Los Angeles 74
Ho Chi Minh City 67
Helsinki 53
Milan 48
Dallas 45
Hanoi 41
Nanjing 41
Izmir 39
Jakarta 37
Shanghai 36
San Diego 35
Tokyo 35
Princeton 33
Bologna 31
Lauterbourg 31
London 29
Boardman 25
Rome 25
São Paulo 23
Nanchang 20
Chicago 19
Jinan 18
Mexico City 18
Montreal 18
Turku 18
Orem 17
Timisoara 17
Atlanta 16
Toronto 16
Turin 16
Buffalo 14
Brno 13
Phoenix 13
Denver 11
Nuremberg 11
Addison 10
Boston 10
Brooklyn 10
Dearborn 10
Manchester 10
Moscow 10
San Francisco 10
Shenyang 10
The Dalles 10
Da Nang 9
Frankfurt am Main 9
Hangzhou 9
Hefei 9
Washington 9
Belo Horizonte 8
Dong Ket 8
Falls Church 8
Haiphong 8
Johannesburg 8
Mountain View 8
Stockholm 8
Tampa 7
Tashkent 7
Vancouver 7
Brussels 6
Changsha 6
Dublin 6
Düsseldorf 6
Hebei 6
Querétaro 6
Ankara 5
Auburn Hills 5
Berkeley 5
Chennai 5
Des Moines 5
Guangzhou 5
Hyderabad 5
Jiaxing 5
Kunming 5
Leeds 5
Ningbo 5
North Bergen 5
Norwalk 5
Paris 5
Poplar 5
Totale 5.365
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 409
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 306
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 303
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 269
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 262
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 252
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 247
MicroRNA involvement in hepatocellular carcinoma 243
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 242
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 232
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 229
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 224
Animal Models of Hepatocellular Carcinoma Prevention 223
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 220
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 217
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 215
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 212
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 208
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 203
MicroRNA response to environmental mutagens in liver 198
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 197
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 196
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 196
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 192
Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients 190
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 176
MicroRNAs in Animal Models of HCC 165
Novel Virus Identification through Metagenomics: A Systematic Review 153
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 142
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 135
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 134
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 119
null 107
null 103
null 89
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 69
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 64
null 63
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 40
Totale 7.748
Categoria #
all - tutte 32.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022386 0 38 52 18 10 29 22 22 17 25 40 113
2022/2023344 32 19 19 46 47 42 40 25 41 0 21 12
2023/2024305 15 35 15 6 21 77 11 39 6 6 7 67
2024/20251.183 30 25 77 35 121 143 61 63 235 114 139 140
2025/20262.855 301 67 189 290 414 176 420 167 275 283 181 92
2026/2027203 64 139 0 0 0 0 0 0 0 0 0 0
Totale 7.748